Skip to content

CRANIOMAX

Active
Private limited companyfounded 2010active for 16 yearsRoze Hoevelaan 13, 1180 Ukkel, BelgiumKBO/BCE: BE 0828.651.697
Summary

CRANIOMAX has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €526,705 and a net result of €45,470. Equity has been growing by about 14% per year since 2018. Its solvency ranks better than 47% of 1,241 sector peers (NACE 86, financial year 2024). The computed 12-month bankruptcy probability is 1.1% (low).

Overview

Official details

Source: KBO
Status
Active since 23-08-2010 Normal situation
Activity
Specialist medical practice NACE 86220
Joint committee
330 Paritair Comité voor de gezondheidsinrichtingen en -diensten · annual accounts 2024
Establishment unit
2.283.817.785 1180 Ukkel, since 23-10-2010
Financial year end
31 December
Peppol
Reachable since 07-04-2026

Board and ownership

Last known board

Financial position

54 Fair Checked score 2024
Bankruptcy probabilitywithin 12 months
1.1%
Annual accounts 2024
Gross margin
€262,718
▼ 16.4%
Turnover
≈ €510,000
estimated
Profit
€45,470
▼ 67.0%
Equity
€526,705
▲ 9.4%
Total assets
€1.0m
▼ 11.5%
Employees on 31-12-2024
1
  • 2025 accounts not filed, 94 days past the deadline
Filed on 26-09-2025
Score breakdownraises riskCapped at 59: a confirmed filing findingLiquidity: current ratio 0.98, cash €6,624Figures for financial year 2024 (filed on 30-09-2025)1 financial year not filed after the legal deadline; last filed accounts filed 57 days late; 3 of the last 3 accounts latelowers riskSector: Human health activities (NACE 86)Show the evidence

Checked score

Score 2024
54 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially stronger than 28% of micro companies in human health (NACE 86)
A confirmed filing finding caps the score at 59. Every signal that counts is listed under Signals.
Financial strength · tick: 2023
Average
Solvency 77+10
equity 51.9% of total assets
Liquidity 31+1
short-term debt 41.4% · cash 0.7%
Profitability 66-18
return on assets 4.5%
Bankruptcy probability within 12 months
1.1% Low
0%0.5%1.5%4%10%≥ 25%

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: 1.6% 01-2025: 2.8%▲ +1.2 percentage points vs 12-2024highest value 02-2025: 0.4%▼ -2.4 percentage points vs 01-2025lowest value 03-2025: 0.4%● unchanged vs 02-2025 04-2025: 0.5%▲ +0.1 percentage points vs 03-2025 05-2025: 0.5%● unchanged vs 04-2025 06-2025: 0.5%● unchanged vs 05-2025 07-2025: 0.6%▲ +0.1 percentage points vs 06-2025 08-2025: 0.9%▲ +0.3 percentage points vs 07-2025 09-2025: 0.9%● unchanged vs 08-2025 10-2025: 0.4%▼ -0.5 percentage points vs 09-2025 11-2025: 0.4%● unchanged vs 10-2025 12-2025: 0.4%● unchanged vs 11-2025 01-2026: 0.4%● unchanged vs 12-2025 02-2026: 0.4%● unchanged vs 01-2026 03-2026: 0.5%▲ +0.1 percentage points vs 02-2026 04-2026: 0.5%● unchanged vs 03-2026 05-2026: 0.4%▼ -0.1 percentage points vs 04-2026 06-2026: 0.5%▲ +0.1 percentage points vs 05-2026 07-2026: 0.5%● unchanged vs 06-2026 08-2026: 0.8%▲ +0.3 percentage points vs 07-2026 09-2026: 0.9%▲ +0.1 percentage points vs 08-2026 10-2026: 1.1%▲ +0.2 percentage points vs 09-2026 11-2026: 1.1%● unchanged vs 10-2026
Credit of up to €25,000 on 30-day terms, only on tighter conditions: an expected filing is missing beyond Checked's processing allowance
Liquidity is insufficient, with a current ratio of 0.98 (0.93 in 2023), below 1. Short-term debt is 41.4% and cash 0.7% of total assets. 48.1% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 42% of them on solvency, 6% on liquidity, 12% on profitability and 52% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises risk
raises risk · Liquidity: current ratio 0.98, cash €6,624
NBB · annual accounts
raises risk · Figures for financial year 2024 (filed on 30-09-2025)
NBB · annual accounts
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · 1 financial year not filed after the legal deadline; last filed accounts filed 57 days late; 3 of the last 3 accounts late
NBB · filings
raises risk · Annual accounts not filed
The financial year that closed on 31-12-2025 was due at the National Bank by 31-07-2026. Nothing is on record, 94 days later.
NBB · 10 filings
Position against the passed deadline
31-12-2025 year end31-07-2026 deadline02-11-2026 today
raises risk · 2024 accounts filed 57 days late
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 26-09-2025, 57 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
not filed
2024
57 days late
2023
160 days late
2022
92 days late
2021
122 days late
2020
121 days late
2019
138 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 6 accounts on average 115 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Result fell in 2024from €137,796 to €45,470 ▼ 67.0% View
  • Positive: 7 profitable years in a rowprofit 2024: €45,470 7 years View

Recent changes

  1. · Gazette deed Resignation: SHAHLA Mohammad (manager)Reappointment: SHAHLA Mohammad (administrateur non statutaire unique)
  2. · Gazette deed Incorporation
All 16 events

Comparable companies

These companies have the same main activity as CRANIOMAX: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €832,000 and €1.1m, founded between 2008 and 2013.

CompanyTotal assetsGross margin
CRANIOMAX Ukkel€1.0m€0.3m
SOCIETE MEDICALE DRS VON FRENCKELL-GILLARD Fernelmont€1.0m€0.3m
Docteur Aurélie LEDOUX Ophtalmologie Namur€0.9m€0.3m
Institut Fovéa Vorst€1.1m€0.3m
GYNEMAJE Etterbeek€0.9m€0.3m
N2DERM Wemmel€0.9m€0.2m
Dr. Vanhee Neurologie Kortrijk€0.8m€0.3m
Full comparison

Key facts about CRANIOMAX

What is the company number of CRANIOMAX?
The company number of CRANIOMAX is 0828.651.697. The VAT number is the same number with BE in front: BE 0828.651.697.
Where is CRANIOMAX based?
The registered office is at Roze Hoevelaan 13, 1180 Ukkel.Company details
What does CRANIOMAX do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of CRANIOMAX?
The legal form of CRANIOMAX is Private limited company (BV).
When was CRANIOMAX founded?
CRANIOMAX was founded on 23-08-2010.
Is CRANIOMAX still active?
Yes, CRANIOMAX is an active enterprise in the KBO register.
How many employees does CRANIOMAX have?
CRANIOMAX had an average of 0.8 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
Which joint committee does CRANIOMAX fall under?
In its 2024 annual accounts, CRANIOMAX states joint committee 330 (Paritair Comité voor de gezondheidsinrichtingen en -diensten).
What is the turnover of CRANIOMAX?
The turnover in financial year 2024 is ≈ €510,000. This figure is estimated from the gross margin of €262,718 and 40 comparable companies (NACE 862). It probably lies between €340,000 and €810,000.
Is CRANIOMAX profitable?
In financial year 2024, CRANIOMAX made a profit of €45,470.
Where can I find the annual accounts of CRANIOMAX?
CRANIOMAX filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2024.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.